Hoffman La-Roche accused of illegally maintaining monopoly over cancer drugs
MLex Summary: Biocad has filed a complaint against F. Hoffman La-Roche and its US subsidiaries, Genentech and R-Farm, for allegedly using their monopoly power to unlawfully keep out competition from generic...To view the full article, register now.
Already a subscriber? Click here to view full article